Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H McLean

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
The Journal of Clinical Investigation|March 1, 1973
Properdin anc C3 proactivator: alternate pathway components in human glomerulonephritisR H McLean, A F Michael
Nephron|January 1, 1980
Activation of the classic complement pathway in patients with the C3 nephritic factorR H McLean, N J Siegel, M Kashgarian
Pediatric Nephrology (Berlin, Germany)|January 1, 1988
Neonatal obstructive uropathyR H McLean, J P Gearhart, R Jeffs
The American Journal of Medicine|May 1, 1985
Hypomorphic variant of the slow allele of C3 associated with hypocomplementemia and hematuriaR H McLean, R K Bryan, J Winkelstein
Clinical and Experimental Immunology|March 1, 1975
The effect of anticomplementary substances on properdin in normal and C2-deficient seraR H McLean, K Townsend, A F Michael
The Annals of Thoracic Surgery|April 10, 1999
Pericardial tamponade: an unusual complication of lobectomy for lung cancerR H McLean, B B Parandian, M H Nam
Archives of Pathology & Laboratory Medicine|December 1, 1986
Idiopathic linear glomerular IgA depositionB Fivush, T Melvin, K Solez, et al.
Seminars in Nephrology|March 1, 1989
Molecular studies of the fourth component of complement (C4) in glomerulonephritisR H McLean, C C Porter, R J Wyatt
International Archives of Allergy and Applied Immunology|January 1, 1973
Determination of serum properdin levels by immunodiffusionN G Westberg, R H McLean, A F Michael
Kidney International|December 1, 1984
Complement phenotypes in glomerulonephritis: increased frequency of homozygous null C4 phenotypes in IgA nephropathy and Henoch-Schönlein purpuraR H McLean, R J Wyatt, B A Julian
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
The Journal of Clinical Investigation|March 1, 1973
Properdin anc C3 proactivator: alternate pathway components in human glomerulonephritisR H McLean, A F Michael
Nephron|January 1, 1980
Activation of the classic complement pathway in patients with the C3 nephritic factorR H McLean, N J Siegel, M Kashgarian
Pediatric Nephrology (Berlin, Germany)|January 1, 1988
Neonatal obstructive uropathyR H McLean, J P Gearhart, R Jeffs
The American Journal of Medicine|May 1, 1985
Hypomorphic variant of the slow allele of C3 associated with hypocomplementemia and hematuriaR H McLean, R K Bryan, J Winkelstein
Clinical and Experimental Immunology|March 1, 1975
The effect of anticomplementary substances on properdin in normal and C2-deficient seraR H McLean, K Townsend, A F Michael
The Annals of Thoracic Surgery|April 10, 1999
Pericardial tamponade: an unusual complication of lobectomy for lung cancerR H McLean, B B Parandian, M H Nam
Archives of Pathology & Laboratory Medicine|December 1, 1986
Idiopathic linear glomerular IgA depositionB Fivush, T Melvin, K Solez, et al.
Seminars in Nephrology|March 1, 1989
Molecular studies of the fourth component of complement (C4) in glomerulonephritisR H McLean, C C Porter, R J Wyatt
International Archives of Allergy and Applied Immunology|January 1, 1973
Determination of serum properdin levels by immunodiffusionN G Westberg, R H McLean, A F Michael
Kidney International|December 1, 1984
Complement phenotypes in glomerulonephritis: increased frequency of homozygous null C4 phenotypes in IgA nephropathy and Henoch-Schönlein purpuraR H McLean, R J Wyatt, B A Julian
Pageof 8